Russell Investments Group
ALXN

Russell Investments Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Russell Investments Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-216,189
Closed -$39.7M – 3315
2021
Q2 		$39.7M Sell
216,189
-18,821
-8% -$3.23M 0.07% 353
2021
Q1 		$35.9M Sell
235,010
-40,915
-15% -$6.33M 0.06% 361
2020
Q4 		$43.1M Sell
275,925
-15,351
-5% -$1.97M 0.09% 270
2020
Q3 		$33.1M Sell
291,276
-6,328
-2% -$683K 0.07% 309
2020
Q2 		$33.3M Buy
297,604
+57,191
+24% +$6.07M 0.07% 290
2020
Q1 		$21.5M Buy
240,413
+160,719
+202% +$15.8M 0.06% 375
2019
Q4 		$8.58M Buy
79,694
+5,042
+7% +$539K 0.02% 922
2019
Q3 		$7.3M Sell
74,652
-8,714
-10% -$982K 0.01% 1006
2019
Q2 		$10.8M Buy
83,366
+42,821
+106% +$5.52M 0.02% 838
2019
Q1 		$5.46M Sell
40,545
-14,298
-26% -$1.78M 0.01% 1193
2018
Q4 		$5.34M Sell
54,843
-4,379
-7% -$518K 0.01% 1116
2018
Q3 		$8.22M Buy
59,222
+6,842
+13% +$858K 0.02% 1030
2018
Q2 		$6.47M Buy
52,380
+15,550
+42% +$1.82M 0.01% 1155
2018
Q1 		$4.08M Buy
36,830
+7,476
+25% +$894K 0.01% 1470
2017
Q4 		$3.53M Sell
29,354
-5,524
-16% -$673K 0.01% 1523
2017
Q3 		$4.89M Sell
34,878
-710
-2% -$96.5K 0.01% 1284
2017
Q2 		$4.33M Buy
35,588
+6,438
+22% +$749K 0.01% 1315
2017
Q1 		$3.54M Buy
29,150
+4,665
+19% +$601K 0.01% 1422
2016
Q4 		$3.02M Buy
+24,485
New +$3M 0.01% 1569

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Russell Investments Group's ALXN Position: Q3 2021 in Review

Russell Investments Group sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 216,189 shares — an estimated $39.7M sold.

Russell Investments Group first reported a position in ALXN in Q4 2016 and held it in 19 quarters. The position peaked at $43.1M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Russell Investments Group reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Russell Investments Group sold 216,189 Alexion Pharmaceuticals shares in Q3 2021, an estimated $39.7M.
  • Russell Investments Group first reported a position in Alexion Pharmaceuticals in Q4 2016 and held it in 19 quarters.
  • Russell Investments Group's Alexion Pharmaceuticals position peaked at $43.1M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Russell Investments Group's 13F filing for Q3 2021, filed 8 Nov 2021.